Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. - Wikidata - wikimedia - TriplyDB

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

http://www.wikidata.org/entity/Q39666021

about

DICOM for quantitative imaging biomarker development: a standards based approach to sharing clinical data and structured PET/CT analysis results in head and neck cancer research Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review Prognostic significance of volume-based PET parameters in cancer patients.State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET 18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user's perspective Characterization of PET/CT images using texture analysis: the past, the present… any future?Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT.PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.PET/CT in Oncology: Current Status and Perspectives.Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT.Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.Correlation of intra-tumor 18F-FDG uptake heterogeneity indices with perfusion CT derived parameters in colorectal cancer.Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas.Association between Volumetric Analysis of Lung Metastases on F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography and Short-term Progression after I-131 Therapy for Differentiated Thyroid Carcinoma.Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response Methodological considerations in quantification of oncological FDG PET studies.Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy Positron Emission Tomography (PET) in Oncology Imaging and cancer: a review.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy.Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.The future of hybrid imaging-part 2: PET/CT.Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies

P2860

Q24658635-C3305006-68E7-4130-A872-A4DBEC3D1B99 Q27009240-AF37FE9A-71AE-4478-B751-466450EFC949 Q27687836-10EA700E-1F65-4663-941B-ADA01108551B Q27694674-99407EC8-4C53-45EC-A135-78074FB9C0BF Q30400422-C3269510-46CD-4159-9995-409FAB9EAFE9 Q30584396-8DECFA3C-B0E1-4A93-B31B-DD18646CE6A2 Q30724225-8DAF196F-8F91-47A7-BBDD-95CC04CB8335 Q30837034-EB0F81A5-18ED-424D-8BF4-D71B4C39587C Q33413585-59D70E1A-5987-4E0F-B773-A59DD88B0D0D Q33517102-9C6A317C-A997-4511-B4F7-9BAAE83213D6 Q33612767-F8172BDE-1992-413E-A096-6CBC89505F6E Q33665109-074D26C5-8620-423E-893C-D4AE08F7CC48 Q33700938-A81418D5-5F75-43DE-A781-ED157EE84D2F Q33750115-B8131601-BDCE-4237-88FC-BDDE5E423549 Q33753620-4E2457F6-AB80-416D-80EC-57C510809820 Q33793870-2209F0EB-BEDA-4F83-902F-41D15ABEF08C Q33797380-13FF129F-E6B5-47C4-8504-5D4DD3491CFF Q33827725-18A2781C-F23F-4627-B242-31043C5B9483 Q33896012-B95202A2-6CBB-4C8C-A542-ACC961E54D1C Q33904549-041ED133-8D9B-4DE7-8E9C-A18E29EA2A76 Q33915164-D3F56ED6-18DA-4556-814B-33FC599E7D8C Q34023973-16316F4E-481A-4DBB-9436-ADA68507C4D3 Q34336023-0286C9C9-555F-4C22-A5EC-A301A07C5E3D Q34382399-14FF1BB0-BB31-4BDA-A16E-8E2EB6FDD9BE Q34517660-610602BC-578D-403B-943B-3825C02D9FEC Q34774840-CA128109-E217-4AD5-9100-4C60FC72D964 Q34977050-B6696EBA-7FA4-49D8-88A5-F50156E6B65F Q34978457-65F97278-F192-4CAE-BF02-9C136ABD9118 Q34998582-22CE38C9-D3AE-48A4-AF98-1F2EBFFB1F6F Q35129698-778BBC55-6096-4E9F-882E-72E48C098B9B Q35151263-DCE1F175-B04E-4B73-AFB1-D4D84D60F22A Q35162720-C1391B03-11D5-4B54-B577-650825C304CE Q35439403-B1C238C7-C5D3-4194-9DD7-2F0BD633175B Q35582133-6D45DFA8-DC95-48B9-845F-D5C0923E2D46 Q35625394-96F12502-26F4-44A7-9F2A-8496C631C134 Q35761121-1D902AD0-438E-4F98-94C1-CDD22684D9A4 Q35786046-E001F015-42B3-441C-82D2-FB8CEAE7337C Q35940876-515AEF2B-F9AA-45D4-8588-9956A329424E Q35961361-4DEE5663-4725-42C9-B61A-3BB02D4C8687 Q35983497-86F9F56C-A40C-416E-A4BC-87A9B67ECBD6

P2860

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

http://www.wikidata.org/entity/Q39666021

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Tumor Treatment Response Based ...... ge in Total Lesion Glycolysis.

@en

Tumor Treatment Response Based ...... ge in Total Lesion Glycolysis.

@nl

type

label

Tumor Treatment Response Based ...... ge in Total Lesion Glycolysis.

@en

Tumor Treatment Response Based ...... ge in Total Lesion Glycolysis.

@nl

prefLabel

Tumor Treatment Response Based ...... ge in Total Lesion Glycolysis.

@en

Tumor Treatment Response Based ...... ge in Total Lesion Glycolysis.

@nl

P1433

Q39666021-B3515F00-7BFF-4BB4-BBBA-545D86FD651F

P1476

Q39666021-8FA43897-EDCB-4174-9BE2-B03228491F29

P2093

Q39666021-0942A7F0-1DE4-4109-9270-6793D48D75AB

Q39666021-12D7E768-EEAB-4DE5-9408-F3F0DDE17F5A

Q39666021-13642F98-8E9A-488F-B248-09BE9612653B

Q39666021-2652C84E-99F5-4FF2-B39D-7E7DE52A520B

Q39666021-5AE75A23-6D0A-4C81-899A-02458FCED551

Q39666021-862CAC6D-9B70-497A-B234-50A554A89633

Q39666021-8D27E12C-50C2-4C53-ADD7-7F9AD990FF12

Q39666021-D05F39E6-D960-4C3F-A9BE-74988555625B

Q39666021-D5EDC40E-FCFF-46B5-9CEF-FA66F5EFC69E

Q39666021-EA6527E1-2A76-46B3-8972-9910FDA8EC79

P304

Q39666021-8E99261E-2123-48B5-A271-C9981AF0670F

P31

Q39666021-4BC1FA79-E4A5-4DE4-90C9-7401663E7472

P356

Q39666021-A23B315E-8DBB-4F9F-AC57-32A001BC385D

P433

Q39666021-428B30AB-22FB-44A2-9380-A471D064F265

P478

Q39666021-265EBF20-E33C-4990-8BBB-38B3A4AE55EC

P50

Q39666021-B9465DD8-03B9-45A2-A606-E7543D4247CB

P577

Q39666021-30F42E72-1CD1-4656-9F91-7AFCFE686B00

P698

Q39666021-959105C4-26AF-40E6-9938-EB5335E32158

P356

S1095-0397(99)00016-3

P1433

Molecular Imaging and Biology

P1476

Tumor Treatment Response Based ...... nge in Total Lesion Glycolysis

@en

P2093

Alfred E. Cohen

http://www.w3.org/2001/XMLSchema#string

Cecille Casilla

http://www.w3.org/2001/XMLSchema#string

Henry W.D. Yeung

http://www.w3.org/2001/XMLSchema#string

Homer A. Macapinlac

http://www.w3.org/2001/XMLSchema#string

John L. Humm

http://www.w3.org/2001/XMLSchema#string

Jose Guillem

http://www.w3.org/2001/XMLSchema#string

Madhu Mazumdar

http://www.w3.org/2001/XMLSchema#string

Martin Karpeh

http://www.w3.org/2001/XMLSchema#string

Neil Srivastava

http://www.w3.org/2001/XMLSchema#string

Robert Downey

http://www.w3.org/2001/XMLSchema#string

P304

159-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1095-0397(99)00016-3

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Melissa Fazzari

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14516540

http://www.w3.org/2001/XMLSchema#string